Rune Labs Applauds the Signing of the National Plan to End Parkinson's Disease
July 03 2024 - 9:00AM
Business Wire
Rune Labs, a leader in precision medicine for Parkinson’s
disease, celebrates the signing of the National Plan to End
Parkinson's Disease into law. This landmark legislation aims to
unite federal and philanthropic efforts to diagnose and treat
Parkinson’s Disease, helping to ensure access to necessary care for
American families.
Brian Pepin, CEO of Rune Labs, expressed his enthusiasm: "The
signing of the National Plan to End Parkinson's Disease into law is
an important milestone in the fight against this debilitating
condition. The stated goals of this legislation to advance early
diagnosis and improve coordination of the care and treatment of
individuals with Parkinson’s are core to our mission at Rune Labs,
and close to the hearts of our patient and clinician users. We look
forward to partnership opportunities with the National Parkinson’s
Project created under this legislation. By leveraging our StrivePD
platform, we aim to fulfill its promise for the hundreds of
thousands of people living with Parkinson’s in the US who currently
struggle to obtain a diagnosis and access quality care.”
Rune Labs has been at the forefront of integrating technology
with patient care. The StrivePD platform uses the Apple Watch and
Apple HealthKit movement-analysis capabilities to automatically
track symptoms such as tremors and dyskinesia (FDA-cleared on the
Apple Watch), providing continuous, real-time data that helps
patients and healthcare providers optimize treatment plans.
StrivePD combines this data with clinical context and AI-derived
models for disease progression and medication response to provide a
comprehensive approach to Parkinson’s care. Additionally, Rune Labs
leverages its unique dataset to improve clinical trial design and
accelerate the development of new therapies.
Benjamin Stecher, a Parkinson’s patient and advocate, shared his
perspective: "As someone who has been living with Parkinson's
disease for many years, I know firsthand the challenges and
frustrations that come with managing this condition. The National
Plan to End Parkinson's Disease represents a new hope for the
entire Parkinson's community, and I am thrilled to see it signed
into law. Through my work with Rune Labs and my advocacy efforts, I
have seen the incredible potential of technology to transform the
lives of those affected by Parkinson's. I am confident that with
continued collaboration and innovation, we can make significant
strides in improving care."
Rune Labs looks forward to collaborating with the Department of
Health and Human Services and other stakeholders to realize the
ambitious objectives of this national plan.
About Rune Labs
Rune Labs is a software and data analytics company for precision
neurology, supporting care delivery and therapy development.
StrivePD is the company's care delivery ecosystem for Parkinson's
disease, enabling patients and clinicians to better manage
Parkinson's by providing access to curated dashboards summarizing a
range of patient data sources, and by connecting patients to
clinical trials. For therapeutics development, biopharma and
medical device companies leverage Rune's technology, network of
engaged clinicians and patients, and large longitudinal real-world
datasets to expedite development programs. The company has received
financial backing from leading investors such as Nexus NeuroTech,
Eclipse Ventures, DigiTx, TruVenturo and Moment Ventures. For more
information, please visit runelabs.io and strive.group.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240703697563/en/
Consort Partners for Rune Labs runelabs@consortpartners.com